Baron Discovery Fund Q3 2025 Contributors And Detractors

Leading defense technology provider Kratos Defense & Security Solutions contributed to performance following a strong ...

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q3 2025 Earnings Call Transcript

Q3 2025 Earnings Call Transcript November 3, 2025 IDEXX Laboratories, Inc. beats earnings expectations. Reported EPS is $3.4, ...

Bruker Corporation (NASDAQ:BRKR) Q3 2025 Earnings Call Transcript

Q3 2025 Earnings Call Transcript November 3, 2025 Bruker Corporation beats earnings expectations. Reported EPS is $0.6, ...
Le Lézard

U.S. FDA approves KYGEVVI® (doxecitine and doxribtimine), the first and only treatment for adults and children living with thymidine kinase 2 deficiency (TK2d)

UCB (Euronext Brussels: UCB), a global biopharmaceutical company, today announced that KYGEVVI® has been granted approval by the U.S. Food and Drug Administration (FDA) for the treatment of adults and ...
AccessWDUN

Crawford & Company Board Declares Quarterly Dividends and Authorizes Additional Share Repurchase

Crawford & Company Board Declares Quarterly Dividends and Authorizes Additional Share RepurchaseThe Associated PressATLANTA ATLANTA–(BUSINESS WIRE)–Nov 3, 2025– On October 30, 2025, at its regular ...